Weekly Recap | Cameco -0.8%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

Cameco (CCJ) closed at $70.73, down 0.8% from Friday’s $71.30. The S&P 500 gained 2.51% over the same stretch, leaving the stock about 3.31 percentage points behind the benchmark. Monday saw an intraday high of $75.605, followed by a steady drift lower through the week. Friday’s low was $70.01, and the weekly range came to 7.62%.

Key Events

Most of the week’s coverage framed Cameco within the broader Canadian nuclear theme. Monday brought a report highlighting CCJ alongside AtkinsRéalis Group, plus a note that some call options had soared 300% after a 4% rally the previous Friday. The same day, a list of three Canadian nuclear stocks to own in November 2026 included CCJ. Tuesday saw a brief intraday gain of nearly 6%. Thursday’s coverage again grouped Cameco with two other Canadian growth stocks. The company itself released no earnings or major announcements this week.

Analyst Ratings

Across 21 covering firms, 12 rate Cameco buy, 7 rate it overweight and 2 rate it hold; none rate it underweight or sell. The consensus recommendation is buy, with a consensus target of $117.80, roughly 66.6% above the latest close. Individual targets range from $83.76 to $172.21, a wide spread. Within the coal and consumable fuels industry, Cameco ranks first among 16 names, where the average firm count is 8.

The Week Ahead

On the macro side, the New York Fed manufacturing index lands on Monday with a forecast of 18 versus a prior 25.5. Tuesday brings retail sales, retail sales ex-autos, industrial production and import prices. Cameco’s fiscal Q4 2026 earnings are not due until 12 February 2027, before market open. There are no company-specific events on next week’s calendar.

In Short

The week’s signals are mixed. Coverage is heavily buy-rated, with a consensus target about two-thirds above spot and an industry rank of first. Yet the stock faded while the broader market rose, and the P/E sits near 108x. Latest-session flows show small and mid-lot net buying against large-lot net selling. The question going forward is whether the nuclear theme holds enough heat, and whether fiscal Q4 results can support the current valuation.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.